# New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye

> **NCT06903741** · PHASE4 · RECRUITING · sponsor: **Laboratoires Thea** · enrollment: 30 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DEVICE:** T2769

## Key facts

- **NCT ID:** NCT06903741
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06903741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06903741, "New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06903741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*